Intern Pocket Cards - Antibiogram and Susceptibilities VRE - MRSA - GRAM POSITIVES - GRAM NEGATIVES - PSEUDOMONAS - ANAEROBES - ATYPICALS - ANAEROBES - ATYPICALS - penicillin, amoxicillin/ampicillin, amox-clav/amp-sulbactam, methicillin/oxacillin, piperacilin-tazobactam/ticarcillin-clavulanate - 1st gen cephalosporins, 2nd gen cephalosporins (cefoxitin,cefotetan), 3rd gen cephalosporins, 4th gen cephalosporins (cefepime), (ceftazidime), 5th gen cephalosporins (ceftaroline) - carbapenems, aztreonam - ceftaz-avi, ceftolozane-tazo, mero-vabor / imi-relee, cefiderocol - TMP-SMX - clindamycin - vancomycin / oritavancin / dalbavancin - daptomycin, linezolid / tedizolid - tetracyclines (doxycycline) - tigecycline / eravacycline / omadacycline - lefamulin - macrolides - quinolones (delafloxacin, moxifloxacin) - aminoglycosides - fosfomycin - colistin / polymyxin B - metronidazole Antimicrobial Stewardship: → What syndrome? (e.g., UTI, bacteremia, etc.) What bug? (Use culture data. If none, what is most likely?) → What drug? (IV or PO?) Check local antibiogram. Initial duration of therapy? → Can I de-escalate? If on IV, can I switch to PO? Can I stop? (Use clinical data like vitals, WBC count and cultures to tailor therapy) → Discharge patient - Confirm type of IV access (if indicated) and if frequency of medication and lab is feasible at discharge destination by Jennifer Fulcher, MD, PhD @FulchJen Full Inpatient Pocket Cards Collection: https://bit.ly/pocketcardset #Antibiogram #Susceptibilities #antibiotics #management #pharmacology
